Home > > > Report Detail

Liquid Biopsy Market, by Cancer (Lung, Breast, Colorectal, etc), Products, Circulating Biomarkers, Sample, Clinical Application, Regions & Companies

Publisher Name :
Date: 31-Jul-2018
No. of pages: 133
Inquire Before Buying

Liquid Biopsy Market is projected to exceed US$ 3.4 Billion by the year 2024, witnessing the worldwide increasing prevalence of cancer and raising awareness regarding the minimal invasive liquid biopsy technology across the world. Today, liquid biopsy has paved the road of cancer diagnosis and treatment by offering a complete treatment response in real time without the need of serial traditional (solid-tissue) biopsies.

Today, the population across the globe is growing and aging and so is the global burden of cancer; it is estimated that by the year 2030, the global cancer burden will reach nearly 21.7 Million new cancer cases and be around 13 Million cancer deaths. It is also expected that the low and middle income countries accounts for 60% of the cancer deaths due to the lack of medical resources and proper healthcare systems.

The cases of cancer increases very rapidly around the world owing to the adoption of unhealthy lifestyles and behaviors such as smoking, poor diet, physical inactivity etc. These rising cases of cancer will drive the liquid biopsy market to thrive in the coming years. As liquid biopsy is a simple and non-invasive technique it enables physicians to discover a range of information about patient’s tumor and provide clues about the treatment that a patient’s needs.

This report titled “Liquid Biopsy Market, by Cancer (Lung Cancer, Breast Cancer, Colorectal Cancer, Prostate Cancer & Others), Product (Kits & Consumables, Instruments and Services), Circulating Biomarkers (Circulating Tumor Cells (CTCs), Circulating Tumor DNA (ctDNA) & Exosomes), Sample (Plasma/Serum, Urine & Others), Clinical Application (Monitoring, Prognosis, Theranostics & Screening), Regions (North America, Europe, Asia-Pacific, Latin America and Middle East/Africa), Companies (Thermo Fisher Scientific Inc., Roche Diagnostics, Bio-Rad Laboratories Inc., Biocept Inc., Biocartis, Myriad Genetics Inc., Genomic Health, NeoGenomics Laboratories, Qiagen)” provides a complete analysis of Global Liquid Biopsy Market.

By Cancer – Lung Cancer Controls the Liquid Biopsy Market

The report studies the market of the following cancer segments: Lung Cancer, Breast Cancer, Colorectal Cancer, Prostate Cancer & Others. Lung cancer and Breast cancer together accounts for the considerable market share in the global liquid biopsy market.

By Product – Majority of Liquid Biopsy Market held by Kits & Consumables

The report studies the market of the following product segments: Kits & consumables, Instruments and Services. More than 90% of liquid biopsy market is comprised by kits & Consumables and Instruments.

By Circulating Biomarkers

The report studies the liquid biopsy market by Circulating Tumor Cells (CTCs), Circulating Tumor DNA (ctDNA) & Exosomes. Circulating Tumor Cells (CTCs) and Circulating Tumor DNA (ctDNA) together holds significant market share

By Sample – Plasma/Serum accounts for the maximum market

In terms of Sample used for liquid biopsy, the global liquid biopsy market has been studied as Plasma/Serum, Urine and Others.

By Clinical Application – Screening Purpose leads the Liquid Biopsy Market

The report studies the market of the following clinical application segments: Monitoring, Prognosis, Theranostics & Screening.

By Region – North America and Europe will drive the Liquid Biopsy Market

North America and Europe together controls the Liquid Biopsy Market. In addition; the report also provides the complete geographical analysis of Asia-Pacific, Latin America and Middle East/Africa Liquid Biopsy Market.

Companies Analysis

Thermo Fisher Scientific Inc., Roche Diagnostics, Bio-Rad Laboratories Inc., Biocept Inc., Biocartis, Myriad Genetics, Inc., Genomic Health, NeoGenomics Laboratories, Qiagen; which has been studied thoroughly in the report.

All the 9 Companies Studied in the Report have been Studied from 3 Points


  • Company Overview

  • Product Portfolio

  • Financial Insight


This market research report provides a complete analysis of the Liquid Biopsy Market, Growth Drivers, Challenges, and their projections for the upcoming years.

By Cancer


  • Lung Cancer

  • Breast Cancer

  • Colorectal Cancer

  • Prostate Cancer

  • Others


By Product


  • Kits & Consumables

  • Instruments

  • Services


By Circulating Biomarkers


  • Circulating Tumor Cells (CTCs)

  • Circulating Tumor DNA (ctDNA)

  • Exosomes


By Sample


  • Plasma/Serum

  • Urine

  • Others


By Clinical Application


  • Monitoring

  • Prognosis

  • Theranostics

  • Screening


By Regions


  • North America

  • Europe

  • Asia-Pacific

  • Latin America

  • Middle East/Africa


By Companies


  • Thermo Fisher Scientific Inc.

  • Roche Diagnostics

  • Bio-Rad Laboratories Inc.

  • Biocept Inc.

  • Biocartis

  • Myriad Genetics, Inc.

  • Genomic Health

  • NeoGenomics Laboratories

  • Qiagen

Liquid Biopsy Market, by Cancer (Lung, Breast, Colorectal, etc), Products, Circulating Biomarkers, Sample, Clinical Application, Regions & Companies

Table of Contents

1. Executive Summary

2. Global - Liquid Biopsy Market

3. Market Share – Global Liquid Biopsy
3.1 By Region
3.2 By Cancer
3.3 By Product
3.4 By Circulating Biomarkers

4. Region - Liquid Biopsy Market
4.1 North America
4.2 Europe
4.3 Asia-Pacific
4.4 Latin America
4.5 Middle East & Africa

5. Cancer - Liquid Biopsy Market
5.1 Lung Cancer
5.2 Breast Cancer
5.3 Colorectal Cancer
5.4 Prostate Cancer
5.5 Others

6. By Product - Liquid Biopsy Market
6.1 Kits & Consumables
6.2 Instruments
6.3 Services

7. Circulating Biomarkers - Liquid Biopsy Market
7.1 Circulating Tumor Cells (CTCs)
7.2 Circulating Tumor DNA (ctDNA)
7.3 Exosomes

8. By Clinical Application - Liquid Biopsy Market
8.1 Monitoring
8.2 Prognosis
8.3 Theranostics
8.4 Screening

9. By Sample - Liquid Biopsy Market
9.1 Plasma / Serum
9.2 Urine
9.3 Others

10. Thermo Fisher Scientific Inc – Company Analysis
10.1 Product Portfolio
10.1.1 Financial Insight

11 Roche Diagnostics – Company Analysis
11.1 Product Portfolio
11.1.1 Financial Insight

12. Bio-Rad Laboratories Inc – Company Analysis
12.1 Product Portfolio
12.1.1 Financial Insight

13. Biocept, Inc. – Company Analysis
13.1 Product Portfolio
13.2 Financial Insight

14. Biocartis – Company Analysis
14.1 Product Portfolio
14.2 Financial Insight

15. Myriad Genetics, Inc – Company Analysis
15.1 Product Portfolio
15.2 Financial Insight

16. Genomic Health – Company Analysis
16.1 Product Portfolio
16.2 Financial Insight

17. NeoGenomics Laboratories – Company Analysis
17.1 Product Portfolio
17.2 Financial Insight

18. Qiagen – Company Analysis
18.1 Product Portfolio
18.2 Financial Insight

19. Growth Drivers
19.1 Real-Time Evaluation, Convenient and Accuracy
19.2 Increasing Demand for Minimally-Invasive Biopsy Techniques
19.3 Technical Advancement & Personalized Therapies

20. Challenges
20.1 Barriers for Liquid Biopsies
20.2 High Cost with Uncertain or Limited Reimbursement for Liquid Biopsy

List of Tables:

Table 4-1: Estimated number of people living with cancer: by nation, at the end of 2010, 2015, 2020 and 2030
Table 4-2: Cancer Statistics Japan - 2017

List of Figures:

Figure 2‑1: Global – Liquid Biopsy Market (Million US$), 2013 – 2017
Figure 2‑2: Global – Forecast for Liquid Biopsy Market (Million US$), 2018 – 2024
Figure 3‑1: By Region – Liquid Biopsy Market Share (%), 2013 – 2017
Figure 3‑2: By Region – Forecast for Liquid Biopsy Market Share (%), 2018 – 2024
Figure 3‑3: By Cancer – Liquid Biopsy Market Share (%), 2013 - 2017
Figure 3‑4: By Cancer – Forecast for Liquid Biopsy Market Share (%), 2018 – 2024
Figure 3‑5: By Product – Liquid Biopsy Market Share (%), 2013 – 2017
Figure 3‑6: By Product – Forecast for Liquid Biopsy Market Share (%), 2018 – 2024
Figure 3‑7: By Circulating Biomarkers – Liquid Biopsy Market Share (%), 2013 – 2017
Figure 3‑8: By Circulating Biomarkers – Forecast for Liquid Biopsy Market Share (%), 2018 – 2024
Figure 4‑1: United State Cancers by rates of New Cancer Cases (Male & Female) - 2015
Figure 4‑2: United State Cancers by rates of Cancer Deaths (Male & Female) - 2015
Figure 4‑3: North America – Liquid Biopsy Market (Million US$), 2013 – 2017
Figure 4‑4: North America – Forecast for Liquid Biopsy Market (Million US$), 2018 – 2024
Figure 4‑5: Europe – Liquid Biopsy Market (Million US$), 2013 – 2017
Figure 4‑6: Europe – Forecast for Liquid Biopsy Market (Million US$), 2018 – 2024
Figure 4‑7: Asia-Pacific – Liquid Biopsy Market (Million US$), 2013 – 2017
Figure 4‑8: Asia-Pacific – Forecast for Liquid Biopsy Market (Million US$), 2018 – 2024
Figure 4‑9: Latin America – Liquid Biopsy Market (Million US$), 2013 – 2017
Figure 4‑10: Latin America – Forecast for Liquid Biopsy Market (Million US$), 2018 – 2024
Figure 4‑11: Middle East & Africa – Liquid Biopsy Market (Million US$), 2013 – 2017
Figure 4‑12: Middle East & Africa – Forecast for Liquid Biopsy Market (Million US$), 2018 – 2024
Figure 5‑1: Lung Cancer – Liquid Biopsy Market (Million US$), 2013 – 2017
Figure 5‑2: Lung Cancer – Forecast for Liquid Biopsy Market (Million US$), 2018 – 2024
Figure 5‑3: Breast Cancer – Liquid Biopsy Market (Million US$), 2013 – 2017
Figure 5‑4: Breast Cancer – Forecast for Liquid Biopsy Market (Million US$), 2018 – 2024
Figure 5‑5: Colorectal Cancer – Liquid Biopsy Market (Million US$), 2013 – 2017
Figure 5‑6: Colorectal Cancer – Forecast for Liquid Biopsy Market (Million US$), 2018 – 2024
Figure 5‑7: Prostate Cancer – Liquid Biopsy Market (Million US$), 2013 – 2017
Figure 5‑8: Prostate Cancer – Forecast for Liquid Biopsy Market (Million US$), 2018 – 2024
Figure 5‑9: Others – Liquid Biopsy Market (Million US$), 2013 – 2017
Figure 5‑10: Others – Forecast for Liquid Biopsy Market (Million US$), 2018 – 2024
Figure 6‑1: Kits & Consumables – Liquid Biopsy Market (Million US$), 2013 - 2017
Figure 6‑2: Kits & Consumables – Forecast for Liquid Biopsy Market (Million US$), 2018 - 2024
Figure 6‑3: Instruments – Liquid Biopsy Market (Million US$), 2013 - 2017
Figure 6‑4: Instruments – Forecast for Liquid Biopsy Market (Million US$), 2018 - 2024
Figure 6‑5: Services – Liquid Biopsy Market (Million US$), 2013 - 2017
Figure 6‑6: Services – Forecast for Liquid Biopsy Market (Million US$), 2018 - 2024
Figure 7‑1: CTCs – Liquid Biopsy Market (Million US$), 2013 – 2017
Figure 7‑2: CTCs – Forecast for Liquid Biopsy Market (Million US$), 2018 – 2024
Figure 7‑3: ctDNA – Liquid Biopsy Market (Million US$), 2013 – 2017
Figure 7‑4: ctDNA – Forecast for Liquid Biopsy Market (Million US$), 2018 – 2024
Figure 7‑5: Exosomes – Liquid Biopsy Market (Million US$), 2013 – 2017
Figure 7‑6: Exosomes – Forecast for Liquid Biopsy Market (Million US$), 2018 – 2024
Figure 8‑1: Monitoring – Liquid Biopsy Market (Million US$), 2013 – 2017
Figure 8‑2: Monitoring – Forecast for Liquid Biopsy Market (Million US$), 2018 – 2024
Figure 8‑3: Prognosis – Liquid Biopsy Market (Million US$), 2013 – 2017
Figure 8‑4: Prognosis – Forecast for Liquid Biopsy Market (Million US$), 2018 – 2024
Figure 8‑5: Theranostics – Liquid Biopsy Market (Million US$), 2013 – 2017
Figure 8‑6: Theranostics – Forecast for Liquid Biopsy Market (Million US$), 2018 – 2024
Figure 8‑7: Screening – Liquid Biopsy Market (Million US$), 2013 – 2017
Figure 8‑8: Screening – Forecast for Liquid Biopsy Market (Million US$), 2018 – 2024
Figure 9‑1: Plasma/Serum – Liquid Biopsy Market (Million US$), 2013 - 2017
Figure 9‑2: Plasma/Serum – Forecast for Liquid Biopsy Market (Million US$), 2018 - 2024
Figure 9‑3: Urine – Liquid Biopsy Market (Million US$), 2013 - 2017
Figure 9‑4: Urine – Forecast for Liquid Biopsy Market (Million US$), 2018 - 2024
Figure 9‑5: Others – Liquid Biopsy Market (Million US$), 2013 - 2017
Figure 9‑6: Others – Forecast for Liquid Biopsy Market (Million US$), 2018 - 2024
Figure 10‑1: Thermo Fisher – Diagnostics Sales (Million US$), 2013 – 2017
Figure 10‑2: Thermo Fisher – Forecast for Diagnostics Sales (Million US$), 2018 – 2024
Figure 11‑1: Roche Diagnostics – Diagnostics Sales (Billion US$), 2013 – 2017
Figure 11-2: Roche Diagnostics – Forecast for Diagnostics Sales (Billion US$), 2018 – 2024
Figure 12-1: Bio-Rad Laboratories – Net Sales (Million US$), 2013 – 2017
Figure 12-2: Bio-Rad Laboratories – Forecast for Net Sales (Million US$), 2018 – 2024
Figure 13-1: Biocept – Revenue (Million US$), 2013 – 2017
Figure 13-2: Biocept – Forecast for Revenue (Million US$), 2018 – 2024
Figure 14-1: Biocartis – Net Sales (Thousand US$), 2013 – 2017
Figure 14-2: Biocartis – Forecast for Net Sales (Thousand US$), 2018 – 2024
Figure 15-1: Myriad Genetics – Molecular Diagnostics Revenue (Million US$), 2013 – 2017
Figure 15-2: Myriad Genetics – Forecast for Molecular Diagnostics Revenue (Million US$), 2018 – 2024
Figure 16-1: Genomic Health – Net Sales (Million US$), 2013 – 2017
Figure 16-2: Genomic Health – Forecast for Net Sales (Million US$), 2018 – 2024
Figure 17-1: NeoGenomics Laboratories – Net Sales (Million US$), 2013 – 2017
Figure 17-2: NeoGenomics Laboratories – Forecast for Net Sales (Million US$), 2018 – 2024
Figure 18-1: Qiagen – Revenue (Million US$), 2013 – 2017
Figure 18-2: Qiagen – Forecast For Revenue (Million US$), 2018 – 2024

  • Global Cytokine Inhibitor Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 85
    The global Cytokine Inhibitor market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. The development prospects of cytokine inhibitors are very broad, and these drugs have many medical applications and researches. Cytokine inhibitors can reduce The activity of cytokines, thereby inhibiting their role in immune responses and reducing The activation of immune cells and The occurrence o......
  • Global Microbial Growth Media Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 93
    Microbial Growth Media is a nutrient component required by microorganisms, containing a variety of trace elements and trace elements, such as copper, iron, zinc, cobalt, manganese, etc. The global Microbial Growth Media market was valued at US$ 8007 million in 2023 and is anticipated to reach US$ 11530 million by 2030, witnessing a CAGR of 5.3% during The forecast period 2024-2030. The market for microbial growth media is essential in microbiology and biotechnology rese......
  • Global Protein Biochip Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 92
    Protein Biochip is a small Protein array used to quickly detect a large number of unknown proteins. It works in a similar way to a DNA chip. First, a large number of known proteins (such as monoclonal antibodies) are placed on a small substrate and then exposed to and reacted with The unknown protein sample. Due to The specific binding between The antigen and The antibody, it can finally be detected by means of laser. The global Protein Biochip market was valued at US$ 145 million i......
  • Global Isothermal Nucleic Acid Amplification Market Research Report 2024
    Published: 08-Jan-2024        Price: US 2900 Onwards        Pages: 103
    Isothermal nucleic acid amplification is referred to isothermal nucleic acid amplification technology. And in this report, we get The statistics on reagents used in isothermal nucleic acid amplification technology. Nucleic acid isothermal amplification is a newer technique that amplifies DNA or RNA specific fragment from few copies to billion-fold copies under a one temperature condition, unlike PCR amplification that needs at least 30-35 thermal cycles to accomplish The reaction. T......
  • Global Microfluidics Market Growth (Status and Outlook) 2024-2030
    Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 134
    According to our LPI (LP Information) latest study, the global Microfluidics market size was valued at US$ 3118.7 million in 2023. With growing demand in downstream market, the Microfluidics is forecast to a readjusted size of US$ 7707.1 million by 2030 with a CAGR of 13.8% during review period. The research report highlights the growth potential of the global Microfluidics market. Microfluidics are expected to show stable growth in the future market. However, product differentiation, re......
  • Global Isothermal Nucleic Acid Amplification Technology (INAAT) Market Growth (Status and Outlook) 2024-2030
    Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 122
    According to our LPI (LP Information) latest study, the global Isothermal Nucleic Acid Amplification Technology (INAAT) market size was valued at US$ 6141.3 million in 2023. With growing demand in downstream market, the Isothermal Nucleic Acid Amplification Technology (INAAT) is forecast to a readjusted size of US$ 11250 million by 2030 with a CAGR of 9.0% during review period. The research report highlights the growth potential of the global Isothermal Nucleic Acid Amplification Technol......
  • Global Cytokines Market Growth 2024-2030
    Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 119
    According to our LPI (LP Information) latest study, the global Cytokines market size was valued at US$ 203730 million in 2023. With growing demand in downstream market, the Cytokines is forecast to a readjusted size of US$ 611910 million by 2030 with a CAGR of 17.0% during review period. The research report highlights the growth potential of the global Cytokines market. Cytokines are expected to show stable growth in the future market. However, product differentiation, reducing costs, an......
  • Global Western Blot Imagers Market Growth 2024-2030
    Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 94
    According to our LPI (LP Information) latest study, the global Western Blot Imagers market size was valued at US$ 406 million in 2023. With growing demand in downstream market, the Western Blot Imagers is forecast to a readjusted size of US$ 578.4 million by 2030 with a CAGR of 5.2% during review period. The research report highlights the growth potential of the global Western Blot Imagers market. Western Blot Imagers are expected to show stable growth in the future market. However, prod......
  • Global Procalcitonin Antibody Market Growth 2024-2030
    Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 125
    According to our LPI (LP Information) latest study, the global Procalcitonin Antibody market size was valued at US$ million in 2023. With growing demand in downstream market, the Procalcitonin Antibody is forecast to a readjusted size of US$ million by 2030 with a CAGR of % during review period. The research report highlights the growth potential of the global Procalcitonin Antibody market. Procalcitonin Antibody are expected to show stable growth in the future market. However, product di......
    • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs